Metastatic breast cancer has been the subject of sustained clinical investigation across multiple research sites.

11 total trials for this combination

Showing top 10 of 11 trials

Trials

NCT ID	Title	Status	Phase
NCT06018337	A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)	ACTIVE_NOT_RECRUITING	PHASE3
NCT01007942	Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer	COMPLETED	PHASE3
NCT02747004	A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer	ACTIVE_NOT_RECRUITING	PHASE2
NCT00337103	E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes	COMPLETED	PHASE3
NCT00428220	A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.	COMPLETED	NA
NCT01633060	A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi	TERMINATED	PHASE3
NCT01989676	A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)	COMPLETED	PHASE3
NCT06016738	OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer	RECRUITING	PHASE3
NCT03786094	Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer	TERMINATED	PHASE3
NCT01528345	Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer	TERMINATED	PHASE2

Related Pages

All Metastatic breast cancer trials All trials in San Miguel de Tucumán, Argentina